Endpoints News 生物医药· Max Bayer·· 2026-10-06AI 评分31
Leerink高级分析师下调Bristol Myers Squibb评级,因担忧其研发管线
Senior Leerink analyst downgrades Bristol Myers, citing pipeline fears
AI 导读
Leerink高级分析师下调Bristol Myers Squibb股票评级。该动作源于分析师对公司关键在研项目前景的怀疑。正文未提供具体管线药物名称或数据支持。
正文
A Leerink analyst is signaling new bearishness in Bristol Myers Squibb, downgrading his view of the company’s stock because of skepticism about some key upcoming …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news